Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet Glostrup, Nordstjernevej 42, 2600 Glostrup, Denmark.
Int J Mol Sci. 2020 Feb 17;21(4):1343. doi: 10.3390/ijms21041343.
Human α-calcitonin gene-related peptide (h-α-CGRP) is a highly potent vasodilator peptide that belongs to the family of calcitonin peptides. There are two forms of CGRP receptors in humans and rodents: α-CGRP receptor predominately found in the cardiovascular system and β-CGRP receptor predominating in the gastrointestinal tract. The CGRP receptors are primarily localized to C and Aδ sensory fibers, where they are involved in nociceptive transmission and migraine pathophysiology. These fibers are found both peripherally and centrally, with extensive perivascular location. The CGRP receptors belong to the class B G-protein-coupled receptors, and they are primarily associated to signaling via Gα proteins. The objectives of the present work were: (i) synthesis of three single-labelled fluorescent analogues of h-α-CGRP by 9-fluorenylmethyloxycarbonyl (Fmoc)-based solid-phase peptide synthesis, and (ii) testing of their biological activity in isolated human, mouse, and rat arteries by using a small-vessel myograph setup. The three analogues were labelled with 5(6)-carboxyfluorescein via the spacer 6-aminohexanoic acid at the chain of Lys or Lys. Circular dichroism (CD) experiments were performed to obtain information on the secondary structure of these fluorescently labelled peptides. The CD spectra indicated that the folding of all three analogues was similar to that of native α-CGRP. The three fluorescent analogues of α-CGRP were successfully prepared with a purity of >95%. In comparison to α-CGRP, the three analogues exhibited similar efficacy, but different potency in producing a vasodilator effect. The analogue labelled at the N-terminus proved to be the most readily synthesized, but it was found to possess the lowest vasodilator potency. The analogues labelled at Lys or Lys exhibited an acceptable reduction in potency (i.e., 3-5 times and 5-10 times less potent, respectively), and thus they have potential for use in further investigations of receptor internalization and neuronal reuptake.
人α-降钙素基因相关肽(h-α-CGRP)是一种高效能的血管扩张肽,属于降钙素肽家族。人类和啮齿动物中有两种 CGRP 受体形式:α-CGRP 受体主要存在于心血管系统,β-CGRP 受体主要存在于胃肠道。CGRP 受体主要定位于 C 和 Aδ感觉纤维,参与伤害性传递和偏头痛病理生理学。这些纤维在周围和中枢都有发现,具有广泛的血管周围位置。CGRP 受体属于 B 类 G 蛋白偶联受体,主要通过 Gα 蛋白信号转导。本工作的目的是:(i)通过 9-芴甲氧羰基(Fmoc)固相肽合成法合成三种单标记荧光 h-α-CGRP 类似物,(ii)通过使用小血管肌描记器装置在分离的人、鼠和大鼠动脉中测试其生物学活性。这三种类似物通过间隔 6-氨基己酸与赖氨酸或赖氨酸链上的 5(6)-羧基荧光素标记。进行圆二色性(CD)实验以获得这些荧光标记肽的二级结构信息。CD 谱表明,所有三种类似物的折叠与天然α-CGRP 的折叠相似。成功制备了三种荧光标记的α-CGRP 类似物,其纯度>95%。与α-CGRP 相比,这三种类似物在产生血管扩张作用方面表现出相似的效力,但效力不同。在 N 末端标记的类似物被证明是最容易合成的,但发现其血管扩张效力最低。在赖氨酸或赖氨酸上标记的类似物表现出可接受的效力降低(即分别降低 3-5 倍和 5-10 倍),因此它们有可能用于进一步研究受体内化和神经元再摄取。